Stock Guru Profile ALR Technologies Inc. (ALRT – OTCBB)
ALR Technology’s Constant Health Companion(TM) formerly known as the ALRT500 system was the first in the US to provide an affordable, portable, and easy to use combination of reminding caregivers or patients to take medications or treatments as well as allowing for remote monitoring by healthcare professionals or family members.
ALRT’s products and services cost to the consumer is more than 50% lower than the next least expensive system.
Studies have proven that the cost of medication non-compliance is great both in terms of health and dollars. The consequence can be death or loss of an organ transplant. These are very serious consequences for the individual and society. Organ transplant is expensive and there are an inadequate number of organs for transplant.
Compliance is defined as a customer filling his/her prescription and taking the correct dose at the correct time.
Economic costs include the fact that payors must reimburse patients for unused medication, and pay again to help patients who did not take their medication and this can include serious relapse and organ rejection.
Unnecessary illness and death is common: a U.S. estimate indicates 125,000 cardiovascular deaths result from non-compliance annually.
The Constant Health Companion system which has been in the development process for five years is now in its second production run and receiving acceptance from the healthcare community.
The Constant Health Companion system provides caregivers the ability to determine a patient’s compliance and allows intervention when a patient is non-compliant which results in short and long term cost savings.
There are many organizations that will benefit from medication compliance. These industries will have the ability to generate definable cost savings with the implementation of medication compliance products.
Disease Management Devices are important to Homecare Providers, Health Insurance Providers, Insurance Payors which include corporations with self insured plans, Pharmaceutical companies, Retail Consumers, and Veterinary Pharmaceutical.
Insurance providers will have the ability to monitor plan members’ compliance and adjust the pricing of their coverage based on adherence of the chronic care members. This will result in the realization of significant return on investment (ROI).
Primary Conditions Served and Benefit by Medication Compliance
Patients with the following chronic conditions can benefit from ALR compliance reminder services:
Chronic Obstructive Pulmonary Disease, Organ Transplant, Mental Health, HIV / AIDS, Congestive Heart failure, Coronary Artery Disease, Diabetes, Parkinson’s disease, Alzheimer’s disease, or anyone with disease or health management regimen, whether it’s only for a four day course of antibiotics, a 16 week injury recovery program, or a long term medication and diagnostic regimen.
ALR Technologies Power Point Presentation.
Source: ALR Technologies, M2 Communications, and Page Minder
Wendy Prabhu, Investor Relations for ALR Technologies, Inc.
Phone: (512) 828-6645
Email: http://www.stockguru.com/blog/alrt@mercomcapital.com
Sidney Chan, CEO
ALRT — ALR Technologies, Inc.
114M Reynolda Village
Winston-Salem, NC 27106
Website: http://www.alrt.com
Phone: (336) 722-2254
SOURCE: ALR Technologies, Inc. and New England Journal of Medicine and Managed Healthcare Executive; Sep2006, Vol. 16 Issue 9, p44-51, 4p
Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/.
Disclosure: Pentony Enterprises LLC was compensated from non-controlling third party $15,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .